The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report.
 
Benjamin Leon Musher
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Exelixis; Exelixis; Exelixis; Exelixis
Speakers' Bureau - Ipsen; Ipsen; Ipsen; Ipsen
Research Funding - Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma
 
Brandon George Smaglo
Speakers' Bureau - Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Wasif Abidi
Research Funding - GI Dynamics; GI Dynamics; GI Dynamics; GI Dynamics
 
Mohamed Othman
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific; Olympus; Olympus; Olympus; Olympus
Research Funding - Abbvie; Abbvie; Abbvie; Abbvie
 
Kalpesh Patel
Consulting or Advisory Role - ConMed; ConMed; ConMed; ConMed
Speakers' Bureau - Abbvie; Abbvie; Abbvie; Abbvie
Travel, Accommodations, Expenses - Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific
 
James Jing
Employment - Radiology Partners; Radiology Partners; Radiology Partners; Radiology Partners
Stock and Other Ownership Interests - Radiology Partners; Radiology Partners; Radiology Partners; Radiology Partners
 
Nir Stanietzky
Employment - Radiology Partners; Radiology Partners; Radiology Partners; Radiology Partners
Leadership - Radiology Partners; Radiology Partners; Radiology Partners; Radiology Partners
Stock and Other Ownership Interests - Radiology Partners; Radiology Partners; Radiology Partners; Radiology Partners
 
Jinyu (Jim) Lu
No Relationships to Disclose
 
Amanda Brisco
Research Funding - Halozyme; Halozyme; Halozyme; Halozyme; Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma
 
Jessica Wenthe
No Relationships to Disclose
 
Benjamin Brenner
Leadership - AlloVir (I); AlloVir (I); AlloVir (I); AlloVir (I)
Stock and Other Ownership Interests - AlloVir (I); AlloVir (I); AlloVir (I); AlloVir (I); Bluebird Bio (I); Bluebird Bio (I); Bluebird Bio (I); Bluebird Bio (I); Markers (I); Markers (I); Markers (I); Markers (I); Tessa Therapeutics (I); Tessa Therapeutics (I); Tessa Therapeutics (I); Tessa Therapeutics (I)
Consulting or Advisory Role - Allogene Therapeutics (I); Allogene Therapeutics (I); Allogene Therapeutics (I); Allogene Therapeutics (I); Bluebird Bio (I); Bluebird Bio (I); Bluebird Bio (I); Bluebird Bio (I); Memgen (I); Memgen (I); Memgen (I); Memgen (I); Unum (I); Unum (I); Unum (I); Unum (I)
Patents, Royalties, Other Intellectual Property - Bellicum Pharmaceuticals (I); Bellicum Pharmaceuticals (I); Bellicum Pharmaceuticals (I); Bellicum Pharmaceuticals (I); Cell Medica (I); Cell Medica (I); Cell Medica (I); Cell Medica (I)
 
Emma Eriksson
No Relationships to Disclose
 
Ann M. Leen
Stock and Other Ownership Interests - Marker Therapeutics; Marker Therapeutics; Marker Therapeutics; Marker Therapeutics; ViraCyte; ViraCyte; ViraCyte; ViraCyte
Consulting or Advisory Role - Marker Therapeutics; Marker Therapeutics; Marker Therapeutics; Marker Therapeutics; Viracyte; Viracyte; Viracyte; Viracyte
Patents, Royalties, Other Intellectual Property - Patents in the field of cell therapy and i have received royalty payments; Patents in the field of cell therapy and i have received royalty payments; Patents in the field of cell therapy and i have received royalty payments; Patents in the field of cell therapy and i have received royalty payments
 
Susan G. Hilsenbeck
No Relationships to Disclose
 
Gustav J. Ullenhag
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Honoraria - Amgen; Amgen; Amgen; Amgen; BMSi; BMSi; BMSi; BMSi; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - BMSi; BMSi; BMSi; BMSi; Immuneed; Immuneed; Immuneed; Immuneed; Incyte; Incyte; Incyte; Incyte; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Sanofi; Sanofi; Sanofi; Sanofi
 
Eric Keith Rowinsky
Employment - Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma
Consulting or Advisory Role - Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma
 
Bambj Grilley
Employment - QB Regulatory Consulting; QB Regulatory Consulting; QB Regulatory Consulting; QB Regulatory Consulting; South TexAs Nuclear pharmAcy (I); South TexAs Nuclear pharmAcy (I); South TexAs Nuclear pharmAcy (I); South TexAs Nuclear pharmAcy (I)
Leadership - Allovir; Allovir; Allovir; Allovir; Allovir; Allovir; Allovir; Allovir
Stock and Other Ownership Interests - Allovir; Allovir; Allovir; Allovir
 
Angelica Sara Ingrid Loskog
Employment - Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma
Leadership - Bioimics; Bioimics; Bioimics; Bioimics; Hansa Biopharma; Hansa Biopharma; Hansa Biopharma; Hansa Biopharma; Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma; Repos Pharma AB; Repos Pharma AB; Repos Pharma AB; Repos Pharma AB; Vivolux; Vivolux; Vivolux; Vivolux
Consulting or Advisory Role - Galderma (I); Galderma (I); Galderma (I); Galderma (I)
Research Funding - Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma
Patents, Royalties, Other Intellectual Property - Alligator bioscience-royalty agreement; Alligator bioscience-royalty agreement; Alligator bioscience-royalty agreement; Alligator bioscience-royalty agreement; Lokon Pharma: royalty agreement; Lokon Pharma: royalty agreement; Lokon Pharma: royalty agreement; Lokon Pharma: royalty agreement
Travel, Accommodations, Expenses - Lokon Pharma; Lokon Pharma; Lokon Pharma; Lokon Pharma